Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
for
Metastatic Breast Cancer, HER2 Low Breast Carcinoma,
Location: Boston MA
Sponsor: Kristina A. Fanucci
Sex: All
Age: 18+
Code: NCT07198724
Phase 1, Phase 2, Recruiting
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Boston MA, New York NY, Fairfax VA, Pittsburgh PA,
Sponsor: TRIANA Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07491497
Phase 1, Phase 2, Recruiting
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
for
Von Hippel-Lindau Disease, Malignant Neoplasms
Location: Boston MA, Philadelphia PA, Pittsburgh PA, Detroit MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07405164
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Boston MA, New York NY, Morristown NJ, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase 3, Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase 3, Recruiting
Germline Testing for Predisposition to Myeloid Malignancies
for
Myeloid Malignancy, Genetic Predisposition to Disease,
Location: Boston MA
Sponsor: Christopher Reilly
Sex: All
Age: 18+
Code: NCT07112287
Recruiting
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Boston MA, New York NY, Durham NC, Sarasota FL,
Sponsor: Bristol-Myers Squibb
Sex: Male
Age: 18+
Code: NCT06067841
Phase 1, Recruiting
Linked Outcomes in Various EEG-Hyperscanning Setups
for
Brain to Brain Communication
Location: Charlestown MA
Sponsor: Spaulding Rehabilitation Hospital
Sex: All
Age: 20 - 60
Code: NCT07385027
Recruiting
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, New Haven CT, Grand Rapids MI,
Sponsor: Ottimo Pharma Limited
Sex: All
Age: 18+
Code: NCT07266428
Phase 1, Phase 2, Recruiting
Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners
for
Young Onset Dementia
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 70
Code: NCT07018726
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Harrison NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase 3, Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for
Chronic Idiopathic Constipation (CIC)
Location: Watertown MA, Springfield MA, Hartsdale NY, Brooklyn NY,
Sponsor: Ardelyx
Sex: All
Age: 18 - 70+
Code: NCT07382167
Phase 3, Recruiting
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
for
Lymphoma
Location: Boston MA, New York NY, New Brunswick NJ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company